Stay updated on Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial page.

Latest updates to the Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial page
- Check2 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check9 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check30 days agoChange Detected403 Forbidden page now appears where the study record used to be, blocking access to the trial's details. The content is replaced by an error screen, indicating an access restriction rather than the study information.SummaryDifference17%

- Check51 days agoChange DetectedAn updated revision tag, v3.6.6, was added, replacing the previous v3.6.5 tag. This indicates a minor update to the page's revision history and does not change the study details or visible content.SummaryDifference0.0%

- Check65 days agoChange DetectedThe update adds a broad set of MeSH terms and related keywords, along with metadata about IPD sharing plans and FDA-regulated product disclosures, expanding the page's searchable metadata and information sections. These changes improve indexing and documentation without altering the study design or participant details.SummaryDifference96%

- Check72 days agoChange DetectedA new revision tag (v3.6.5) was added, indicating an update to the page's metadata while the main study details appear unchanged.SummaryDifference16%

Stay in the know with updates to Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial page.